» Articles » PMID: 32790106

Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk Factors, and Outcomes

Abstract

Coronavirus disease 2019 (COVID-19) has become a pandemic, but its reported characteristics and outcomes vary greatly amongst studies. We determined pooled estimates for clinical characteristics and outcomes in COVID-19 patients including subgroups by disease severity (based on World Health Organization Interim Guidance Report or Infectious Disease Society of America/American Thoracic Society criteria) and by country/region. We searched Pubmed, Embase, Scopus, Cochrane, Chinese Medical Journal, and preprint databases from 1 January 2020 to 6 April 2020. Studies of laboratory-confirmed COVID-19 patients with relevant data were included. Two reviewers independently performed study selection and data extraction. From 6007 articles, 212 studies from 11 countries/regions involving 281 461 individuals were analyzed. Overall, mean age was 46.7 years, 51.8% were male, 22.9% had severe disease, and mortality was 5.6%. Underlying immunosuppression, diabetes, and malignancy were most strongly associated with severe COVID-19 (coefficient =  53.9, 23.4, 23.4, respectively, all P < .0007), while older age, male gender, diabetes, and hypertension were also associated with higher mortality (coefficient = 0.05 per year, 5.1, 8.2, 6.99, respectively; P = .006-.0002). Gastrointestinal (nausea, vomiting, abdominal pain) and respiratory symptoms (shortness of breath, chest pain) were associated with severe COVID-19, while pneumonia and end-organ failure were associated with mortality. COVID-19 is associated with a severe disease course in about 23% and mortality in about 6% of infected persons. Individuals with comorbidities and clinical features associated with severity should be monitored closely, and preventive efforts should especially target those with diabetes, malignancy, and immunosuppression.

Citing Articles

COVID-19 clinical presentation, management, and epidemiology: a concise compendium.

Maison D, Tasissa H, Deitchman A, Peluso M, Deng Y, Miller F Front Public Health. 2025; 13:1498445.

PMID: 39957982 PMC: 11826932. DOI: 10.3389/fpubh.2025.1498445.


Impact of vaccination against SARS-CoV-2 on mortality risk, ICU admission rate, and hospitalization length in hospitalized COVID-19 patients: a cross-sectional study.

Maleki B, Sadeghian A, Ranjbar M BMC Infect Dis. 2025; 25(1):144.

PMID: 39885405 PMC: 11783754. DOI: 10.1186/s12879-025-10530-4.


Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter study.

Nirmalarajah K, Aftanas P, Barati S, Chien E, Crowl G, Faheem A BMC Infect Dis. 2025; 25(1):132.

PMID: 39875869 PMC: 11773898. DOI: 10.1186/s12879-025-10450-3.


Comparison of COVID-19 and Non-COVID-19 Tracheostomised Patients: Complications, Survival, and Mortality Risk Factors.

Mesalles-Ruiz M, Alonso M, Cruellas M, Plana M, Penella A, Portillo A J Clin Med. 2025; 14(2).

PMID: 39860640 PMC: 11765842. DOI: 10.3390/jcm14020633.


ACCREDIT: Validation of clinical score for progression of COVID-19 while hospitalized.

Melo V, do Brasil P Glob Epidemiol. 2025; 9():100181.

PMID: 39850445 PMC: 11754157. DOI: 10.1016/j.gloepi.2024.100181.


References
1.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

3.
Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

4.
Wang Y, Liu Y, Liu L, Wang X, Luo N, Li L . Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China. J Infect Dis. 2020; 221(11):1770-1774. PMC: 7184401. DOI: 10.1093/infdis/jiaa119. View

5.
Baloch S, Baloch M, Zheng T, Pei X . The Coronavirus Disease 2019 (COVID-19) Pandemic. Tohoku J Exp Med. 2020; 250(4):271-278. DOI: 10.1620/tjem.250.271. View